Use of 4-Factor Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric Patients

Abstract

Get full access to this article

View all access options for this article.

References

Prothrombin complex concentrate (human), Kcentra^® [1.14.1.3 draft labeling text]. King of Prussia, PA: CSL Behring; 2013.

Johansen

Wikkelsø

Lunde

Wetterslev

Afshari

. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev. 2015;(7):CD010555. doi:10.1002/14651858.CD010555.pub2.

Sarode

Milling

Jr Refaai

. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-1243. doi:10.1161/CIRCULATIONAHA.113.002283.

Dickneite

. Prothrombin complex concentrates as reversal agents for new oral anticoagulants. Clin Lab Med. 2014;34:623-635.

Baumann Kreuziger

Keenan

Morton

Dries

. Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates. Biomed Res Int. 2014;20:1-7.